Products/Services Used | Details | Operation |
---|---|---|
Peptide Synthesis> | 5 mg/mL Accurate Chemical & Scientific Corporation #A1090S OVA peptide (323-339) GenScript #RP10610 Human IL-2 Peprotech #200-02 1,2-dioleoyl-sn-glycero-3-phosphocholine Avanti Polar Lipids #860377P 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl) iminodiacetic acid) succinyl]-Ni Avanti Polar Lipids #790404P Human HVEM-Fc-His Simon Davis Laboratory N/A Human ICAM1-His Michael Dustin Laboratory N/A Human CD40-His Michael Dustin Laboratory N/A Human CD80-His Michael Dustin Laboratory N/A Anti-Human CD3 FaB-His (clone UCHT1) Michael Dustin Laboratory N/A SNAP-Cell 647-SiR ligand New England Biolabs #S9102 Human CD58-His Michael Dustin Laboratory N/A Human PDL1-His Michael Dustin Laboratory N/A Critical Commercial Assays Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit 100 Tests Invitrogen #C10635 RosetteSep Human CD4+ T Cell Enrichment Cocktail StemCell Technologies #15062 Anti-Human CD3/CD28 Dynabeads GIBCO #111....08 mM OVA 323-339 peptide (GenScript) antigen or no antigen for 2 h at 37 C. | Get A Quote |
The tumor necrosis factor receptor superfamily member HVEM is one of the most frequently mutated surface proteins in germinal center (GC)-derived B?cell lymphomas. We found that HVEM deficiency increased B cell competitiveness during pre-GC and GC responses. The immunoglobulin (Ig) superfamily protein BTLA regulated HVEM-expressing B?cell responses independently of B-cell-intrinsic signaling via HVEM or BTLA. BTLA signaling into T?cells through the phosphatase SHP1 reduced T?cell receptor (TCR) signaling and preformed CD40 ligand mobilization to the immunological synapse, thus diminishing the help delivered to B cells. Moreover, T?cell deficiency in BTLA cooperated with B cell Bcl-2 overexpression, leadin... More